Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masami; FUJIWARA, Yoshiro et al.Oncology reports. 2007, Vol 17, Num 5, pp 983-987, issn 1021-335X, 5 p.Article

Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancerSOH, Junichi; TOYOOKA, Shinichi; KIURA, Katsuyuki et al.International journal of cancer. 2007, Vol 121, Num 5, pp 1162-1167, issn 0020-7136, 6 p.Article

Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoterOHASHI, Kadoaki; RAI, Kammei; KIURA, Katsuyuki et al.Cancer science. 2008, Vol 99, Num 9, pp 1747-1753, issn 1347-9032, 7 p.Article

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapyHOTTA, Katsuyuki; FUJIWARA, Yoshiro; MATSUO, Keitaro et al.Cancer. 2007, Vol 109, Num 5, pp 939-948, issn 0008-543X, 10 p.Article

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancerHOTTA, Katsuyuki; SUZUKI, Etsuji; HISAMOTO-SATO, Akiko et al.Lung cancer. 2013, Vol 79, Num 1, pp 20-26, issn 0169-5002, 7 p.Article

Being overweight influences the development of hepatic dysfunction in Japanese patients with non-small-cell lung cancer undergoing cytotoxic chemotherapyFUJIWARA, Yoshiro; KIURA, Katsuyuki; HOTTA, Katsuyuki et al.Lung cancer. 2007, Vol 55, Num 3, pp 343-348, issn 0169-5002, 6 p.Article

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancerHOSOKAWA, Shinobu; TOYOOKA, Shinichi; KIURA, Katsuyuki et al.Lung cancer. 2009, Vol 66, Num 1, pp 107-113, issn 0169-5002, 7 p.Article

Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung : Okayama Lung Cancer Study Group experienceHOTTA, Katsuyuki; KIURA, Katsuyuki; KAMEI, Haruhito et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 1, pp 117-123, issn 0171-5216, 7 p.Article

Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinibFUJIWARA, Yoshiro; KIURA, Katsuyuki; DATE, Hiroshi et al.Lung cancer. 2008, Vol 59, Num 1, pp 81-87, issn 0169-5002, 7 p.Article

Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in japanese patients with non-small cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TABATA, Masahiro et al.Anticancer research. 2007, Vol 27, Num 3B, pp 1737-1742, issn 0250-7005, 6 p.Article

CHALLENGES TO THE ASSESSMENT OF BENTHIC POPULATIONS AND BIODIVERSITY AS A RESULT OF RHYTHMIC BEHAVIOUR: VIDEO SOLUTIONS FROM CABLED OBSERVATORIESAGUZZI, Jacopo; COMPANY, Joan B; CLINE, Danelle et al.Oceanography and marine biology. 2012, Vol 50, pp 235-285, issn 0078-3218, 51 p.Article

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinomaTOYOOKA, Shinichi; TAKANO, Toshimi; AOE, Keisuke et al.Cancer science. 2008, Vol 99, Num 2, pp 303-308, issn 1347-9032, 6 p.Article

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2008, Vol 62, Num 2, pp 236-241, issn 0169-5002, 6 p.Article

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer : Experience at a single institutionMATSUO, Keitaro; KIURA, Katsuyuki; SHINAGAWA, Katsuji et al.American journal of hematology. 2006, Vol 81, Num 5, pp 349-354, issn 0361-8609, 6 p.Article

Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implicationsSEGAWA, Yoshihiko; TAKATA, Saburo; NISHIMURA, Rieko et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 8, pp 1055-1059, issn 0171-5216, 5 p.Article

Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lungSUEHISA, Hiroshi; TOYOOKA, Shinichi; DATE, Hiroshi et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3952-3957, issn 0732-183X, 6 p.Article

The impact of epidermal growth factor receptor gene status on gefitinib-treated japanese patients with non-small-cell lung cancerICHIHARA, Shuji; TOYOOKA, Shinichi; AOE, Motoi et al.International journal of cancer. 2007, Vol 120, Num 6, pp 1239-1247, issn 0020-7136, 9 p.Article

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancerSEGAWA, Yoshihiko; HOTTA, Katsuyuki; UMEMURA, Shigeki et al.Cancer. 2006, Vol 107, Num 8, pp 1866-1872, issn 0008-543X, 7 p.Article

Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancerFUJIWARA, Yoshiro; KIURA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2006, Vol 52, Num 1, pp 99-103, issn 0169-5002, 5 p.Article